A rare, but serious, constellation of symptoms, termed serotonin syndrome, has been reported with the concomitant use of selective serotonin reuptake inhibitors (SSRIs) and agents for migraine therapy, such as Imitrex (sumatriptan succinate) and dihydroergotamine.
<selective serotonin reuptake inhibitors, effect, Imitrex>, <selective serotonin reuptake inhibitors, effect, sumatriptan succinate>, <selective serotonin reuptake inhibitors, effect, dihydroergotamine>, <SSRIs, effect, Imitrex>, <SSRIs, effect, sumatriptan succinate>, <SSRIs, effect, dihydroergotamine>